Endoscopic sleeve gastroplasty (ESG) is a non-surgical, minimally invasive weight-loss procedure where the stomach is reduced in size using sutures placed through an endoscope. Unlike surgical sleeve gastrectomy, ESG does not involve any incisions and has a quicker recovery time. It is recommended for individuals who want to avoid surgery but need help with significant weight loss.

Semaglutide is a weight-loss medication that mimics a hormone regulating appetite and food intake. In the UK, it is marketed under the brand names Ozempic (for diabetes) and Wegovy (for obesity). It is prescribed to individuals struggling with weight management, often in conjunction with diet and exercise.

A weight-loss shot refers to medications like Wegovy (semaglutide), which are injected to aid weight loss. These drugs work by mimicking a hormone that targets areas of the brain responsible for appetite, helping individuals feel full with less food. These injections are typically prescribed for patients with obesity or related health issues.

A mass in the stomach refers to an abnormal growth or lump, which could be benign (non-cancerous) or malignant (cancerous). It may present with symptoms such as pain, bloating, or unexplained weight loss. Diagnostic tests like imaging or a biopsy are essential for determining the nature of the mass and whether surgical removal or further treatment is required.

Wegovy (semaglutide) is a medication that helps with weight loss by mimicking a hormone that regulates appetite. It is prescribed to individuals with obesity or those with weight-related health problems. In the UK, Wegovy has been approved for NHS use for patients who meet certain criteria, providing a non-surgical option for those seeking medical weight-loss assistance.

Antalya offers comprehensive weight-loss surgery packages that include various bariatric procedures at competitive prices. Patients often choose Antalya due to the lower costs, experienced surgeons, and high success rates in surgeries like gastric sleeve and bypass.

The cost of Roux-en-Y gastric bypass surgery varies based on location, healthcare provider, and whether the patient has insurance coverage. In the U.S., the cost ranges from $20,000 to $30,000, depending on the hospital and specific circumstances. In countries with public healthcare systems, such as the UK or Canada, the surgery may be covered, though waiting times could be long. Many insurance companies in the U.S. cover bariatric surgery if it’s deemed medically necessary, but patients must meet specific... +More

The sleeve stomach refers to the portion of the stomach left after gastric sleeve surgery. This new, smaller stomach holds less food and limits calorie intake, contributing to weight loss. Patients must follow a strict diet post-surgery to avoid complications and ensure successful long-term results.

The gastric balloon is a non-surgical weight-loss option where a balloon is inserted into the stomach and inflated to reduce food intake. In the UK, this procedure typically costs between £1,450 and £1,450, depending on the clinic and the type of balloon used.

Abdominal surgery covers a wide range of procedures, from bariatric surgeries to hernia repairs and cancer resections. Recovery time and hospital stay depend on the type of surgery performed, with some requiring only a few days in the hospital, while others may need extended stays for observation and healing.

The NHS in the UK has started prescribing Wegovy to patients who struggle with obesity and have failed to achieve significant weight loss through diet and exercise. This medication is part of a broader initiative to provide patients with additional tools to combat the obesity epidemic. Wegovy is typically prescribed alongside lifestyle changes to maximize its effectiveness.